Ikarian Capital’s Biomea Fusion BMEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,077,600
Closed -$16.1M 123
2024
Q1
$16.1M Buy
1,077,600
+300,000
+39% +$4.94M 1.77% 16
2023
Q4
$11.3M Buy
+777,600
New +$9.45M 1.06% 31
2023
Q3
Sell
-936,800
Closed -$20.6M 153
2023
Q2
$20.6M Buy
936,800
+645,800
+222% +$20.2M 3.27% 4
2023
Q1
$9.02M Buy
+291,000
New +$3.62M 2.05% 13

Other funds holding BMEA

Ikarian Capital's BMEA Position: Q3 2023 in Review

Ikarian Capital sold out of Biomea Fusion (BMEA) in Q3 2023, closing a stake of 275,875 shares — an estimated $6.06M sold.

Ikarian Capital first reported a position in BMEA in Q1 2023 and held it in 2 quarters. The position peaked at $6.54M in Q1 2023. 85 funds tracked by Wall St. Rank hold BMEA as of Q3 2023.

  • Ikarian Capital reported no remaining Biomea Fusion position as of Q3 2023 after selling out during the quarter.
  • Ikarian Capital sold 275,875 Biomea Fusion shares in Q3 2023, an estimated $6.06M.
  • Ikarian Capital first reported a position in Biomea Fusion in Q1 2023 and held it in 2 quarters.
  • Ikarian Capital's Biomea Fusion position peaked at $6.54M in Q1 2023.
  • 85 funds tracked by Wall St. Rank held Biomea Fusion as of Q3 2023.

Based on Ikarian Capital's 13F filing for Q3 2023, filed 14 Nov 2023.